1 |
Imbriani P, Martella G, Bonsi P, Pisani A. Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease. Neurobiol Dis 2022;173:105851. [PMID: 36007757 DOI: 10.1016/j.nbd.2022.105851] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
2 |
Karayel O, Virreira Winter S, Padmanabhan S, Kuras YI, Vu DT, Tuncali I, Merchant K, Wills AM, Scherzer CR, Mann M. Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease. Cell Rep Med 2022;3:100661. [PMID: 35732154 DOI: 10.1016/j.xcrm.2022.100661] [Reference Citation Analysis]
|
3 |
Karayel O, Winter SV, Padmanabhan S, Kuras YI, Vu DT, Tuncali I, Merchant K, Wills A, Scherzer CR, Mann M. Proteome Profiling of Cerebrospinal Fluid Reveals Novel Biomarker Candidates for Parkinson’s Disease.. [DOI: 10.1101/2021.07.22.453322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
4 |
Huntington TE, Srinivasan R. Adeno-Associated Virus Expression of α-Synuclein as a Tool to Model Parkinson's Disease: Current Understanding and Knowledge Gaps. Aging Dis 2021;12:1120-37. [PMID: 34221553 DOI: 10.14336/AD.2021.0517] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
5 |
Barber Janer A, Vonck E, Baekelandt V. Modeling synucleinopathies in rodents. International Review of Movement Disorders 2021. [DOI: 10.1016/bs.irmvd.2021.09.001] [Reference Citation Analysis]
|